| |
|
|
|
Acura Pharmaceuticals Inc.  
|
|
0.25 0.039 (0.18%) |
11-27 12:03 |
|
Open: |
0.25 |
Pre close: |
0.211 |
Target:
|
0.31
|
|
High: |
0.25 |
Low: |
0.25 |
Resistance:
|
0.27
0.31
|
|
Volume: |
1,636 |
Market Cap: |
5M |
Support:
|
0.20
0.17
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.26
 |
MACD |
MACD(12,26):
|
-0.00 |
|
MA(20): |
0.25  |
Signal(12,26,9): |
0.00 |
|
MA(100): |
0.26 |
Stochastic Oscillator |
%K(14,3):
|
42.42 |
|
MA(250): |
0.29 |
%D(3): |
52.53 |
|
Average Volume(K) |
3-Month: |
841
|
52-Week |
High:
|
0.47 |
|
10-Days: |
895 |
Low: |
0.12 |
|
RSI |
RSI(14):
|
49.73 |
Change(%): |
-39.0 |
|
Financials, Statistics and Valuation |
|
EPS |
0.002 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
21.65 |
|
EPS Est. Current Year |
-0.460 |
Return on Assets (ttm) |
29.7 |
Shares Float (M) |
7.49 |
|
EPS Est. Next Year |
0.370 |
PEG Ratio |
0.00 |
% Held by Insiders |
52.81 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
2837.0 |
% Held by Institutions |
9.05 |
|
Forward EPS |
-0.140 |
Gross Profit (p.s.) |
0.053 |
Shares Short (K) |
90 |
|
Book Value (p.s.) |
-0.230 |
EBITDA (p.s.) |
0.065 |
P/E |
125.00 |
|
Sales Per Share |
0.230 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-1.09 |
|
Profit Margin |
1.36 |
Operating Cash Flow
(M) |
1.03 |
P/S |
1.08 |
|
Operating Margin |
23.79 |
Levered Free Cash Flow
(M) |
0.43 |
P/CF |
5.25 |
|
|
|
|
|
|
